Nepsis Inc. United Therapeutics Corp Transaction History
Nepsis Inc.
- $674 Million
- Q4 2024
A detailed history of Nepsis Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Nepsis Inc. holds 54,921 shares of UTHR stock, worth $20.4 Million. This represents 2.87% of its overall portfolio holdings.
Number of Shares
54,921
Previous 51,808
6.01%
Holding current value
$20.4 Million
Previous $18.6 Million
4.38%
% of portfolio
2.87%
Previous 4.6%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
677Shares Held
42.2MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.64 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.18 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.06 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$831 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.9B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...